Sumatriptan induced brugada syndrome, a rare presentation of a commonly used drug

Authors

Phool Iqbal, Department of Internal Medicine New York Medical College/Metropolitan Hospital Center New York New York USA.
Saba Nabavi Monfared, Hamad Medical Corporation Emergency and Trauma Clinical Pharmacy Department Doha Qatar.
Daniel Hernan Sacoto, Department of Internal Medicine New York Medical College/Metropolitan Hospital Center New York New York USA.
Mustafa Bilal Ozbay, Department of Internal Medicine New York Medical College/Metropolitan Hospital Center New York New York USA.
Wael Abdelmottaleb, Department of Internal Medicine New York Medical College/Metropolitan Hospital Center New York New York USA.
Valentina Turbay Caballero, Advocate Health - MidwestFollow
Muhammad Khalid Tahir, Department of Internal Medicine New York Medical College/Metropolitan Hospital Center New York New York USA.
Savi Mushiyev, Department of Cardiology New York Medical College/Metropolitan Hospital Center New York New York USA.

Recommended Citation

Iqbal P, Monfared SN, Sacoto DH, et al. Sumatriptan Induced Brugada Syndrome, a Rare Presentation of a Commonly Used Drug. Clin Case Rep. 2025;13(6):e70417. Published 2025 Jun 3. doi:10.1002/ccr3.70417

Affiliations

Advocate Christ Medical Center

Abstract

We aim to highlight an important and rare association of Brugada Syndrome with a commonly used medication, Sumatriptan, which is used as an aborting Migraine headaches. This life-threatening condition needs early diagnosis and prompt management with vigilant follow-up for better patient outcomes.

Type

Article

PubMed ID

40469122